Share Email Print
cover

Proceedings Paper

Spectrofluorimetric analysis in vivo: applications to kinetics of ALA-induced fluorescence
Author(s): Veronique Vonarx-Coinsmann; S. Cordel; P. Lenz; Marie-Therese Foultier; Roy H. Pottier; James C. Kennedy; Thierry Patrice
Format Member Price Non-Member Price
PDF $14.40 $18.00

Paper Abstract

We designed a laser spectrofluorimeter to determine the optimal delay between drug injection and laser irradiation in which both excitation and fluorescence emission are transmitted through a single optic fiber. Preclinical studies were performed in nude mice after ALA administration. The maximum fluorescence (632 nm) in HT 29 tumors was obtained after 90 min (excitation 488 nm, 20 mW, integration time 3 sec, ALA 250 mg/kg), after 180 min in liver. Iron chelators as EDTA (10 or 20 mg/kg) or desferrioxamine (20 or 40 mg/kg) increased the delay for reaching maximum fluorescence to 2 hours as well as fluorescence intensity in tumors but decreased intensity in liver. Desferrioxamine induced the appearance of protoporphyrin IX in the bladder or kidneys, normally absent in urines. These results indicate that drug distribution varies with tissues and also adjuvant therapies that are often administered together with cancer drugs.

Paper Details

Date Published: 15 January 1994
PDF: 8 pages
Proc. SPIE 2081, Optical Biopsy, (15 January 1994); doi: 10.1117/12.166816
Show Author Affiliations
Veronique Vonarx-Coinsmann, Hopital Laennec (France)
S. Cordel, Hopital Laennec (France)
P. Lenz, INSERM (France)
Marie-Therese Foultier, Hopital Laennec (France)
Roy H. Pottier, Royal Military College of Canada (Canada)
James C. Kennedy, Royal Military College of Canada (Canada)
Thierry Patrice, Hopital Laennec (France)


Published in SPIE Proceedings Vol. 2081:
Optical Biopsy

© SPIE. Terms of Use
Back to Top